ScholarIQanswers from OpenAlex

Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy

PaperCitations, authors & open-access status

Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy have?

ScholarIQcitation count

Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy has 79 citations in the OpenAlex counts ScholarIQ stores.

When was Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy published?

ScholarIQyear

Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy has 2011 year in the ScholarIQ index.

What is the open-access status of Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy?

ScholarIQoa status

Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy has closed oa status in the ScholarIQ index.

What is the DOI of Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy?

ScholarIQdoi

The DOI for Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy is on the source record.

What is the PMID of Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy?

ScholarIQpmid

The PMID for Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy is on the source record.

What is the OpenAlex record for Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy?

ScholarIQopenalex

The OpenAlex for Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial